Hexavest Inc. grew its stake in shares of Envision Healthcare Co. (NYSE:EVHC) by 1.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 655,516 shares of the company’s stock after acquiring an additional 7,270 shares during the quarter. Hexavest Inc. owned about 0.54% of Envision Healthcare worth $22,655,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in EVHC. Janus Henderson Group PLC boosted its holdings in shares of Envision Healthcare by 36,086.8% in the second quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock worth $247,239,000 after buying an additional 3,934,185 shares during the last quarter. OZ Management LP purchased a new position in shares of Envision Healthcare in the third quarter worth approximately $131,987,000. Maverick Capital Ltd. boosted its holdings in shares of Envision Healthcare by 66.2% in the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after buying an additional 2,028,026 shares during the last quarter. Lord Abbett & CO. LLC boosted its holdings in shares of Envision Healthcare by 259.6% in the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock worth $82,808,000 after buying an additional 953,928 shares during the last quarter. Finally, Westfield Capital Management Co. LP purchased a new position in shares of Envision Healthcare in the second quarter worth approximately $45,892,000.
EVHC has been the topic of a number of research reports. Robert W. Baird reissued a “buy” rating and issued a $70.00 price objective on shares of Envision Healthcare in a report on Tuesday, October 17th. SunTrust Banks set a $55.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Sunday, October 15th. Bank of America decreased their target price on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. KeyCorp set a $67.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Wednesday, November 1st. Finally, Jefferies Group set a $71.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the company. Envision Healthcare presently has an average rating of “Hold” and an average target price of $40.73.
Shares of Envision Healthcare Co. (EVHC) opened at $35.83 on Friday. The stock has a market cap of $4,214.20, a P/E ratio of -7.17, a PEG ratio of 0.91 and a beta of 0.58. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89. Envision Healthcare Co. has a 1 year low of $23.77 and a 1 year high of $73.00.
Envision Healthcare (NYSE:EVHC) last released its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.08). The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The company’s quarterly revenue was up 142.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.13 EPS. sell-side analysts expect that Envision Healthcare Co. will post 2.49 EPS for the current year.
Envision Healthcare Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.